ATXS Overview
Upcoming Projects (ATXS)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ATXS)
-
Investigating the proof-of-concept results from the ALPHA-STAR phase 1b/2 clinical trial of Astria Therapeutics' STAR-0215 for HAE
Ticker: ATXS
Executed On: Apr 11, 2024 at 02:00 PM EDT -
Exploring the Future of Hereditary Angioedema Treatment: A Deep Dive into Pharvaris's Deucrictibant and Astria Therapeutics' STAR-0215 Developments
Tickers: PHVS, ATXS
Executed On: Feb 07, 2024 at 04:30 PM EST -
An overview of the hereditary angioedema (HAE) treatment landscape with a focus on new therapies in development by Kalvista, Astria, and Pharvaris
Tickers: PHVS, KALV, ATXS
Executed On: Apr 05, 2023 at 04:00 PM EDT
Upcoming & Overdue Catalysts (ATXS)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (ATXS)
-
Don’t see a strategic initiative related to the company you care about? Create your own!